Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.5 USD | -0.09% | -0.09% | 0.00% |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 217.6 | 214.6 | 209.1 | 94.73 | 200.5 | 196.3 |
Enterprise Value (EV) 1 | 212.2 | 220.6 | 218.2 | 91.59 | 222.2 | 224.1 |
P/E ratio | 63.3 x | 147 x | 176 x | -25.1 x | -42.3 x | 102 x |
Yield | 0.24% | 0.08% | 0.08% | 0.36% | - | - |
Capitalization / Revenue | 0.89 x | 0.87 x | 0.84 x | 0.37 x | 0.76 x | 0.76 x |
EV / Revenue | 0.87 x | 0.89 x | 0.88 x | 0.35 x | 0.84 x | 0.87 x |
EV / EBITDA | - | - | - | - | - | - |
EV / FCF | 62.1 x | -140 x | 36.2 x | -28.7 x | -47 x | -104 x |
FCF Yield | 1.61% | -0.72% | 2.76% | -3.48% | -2.13% | -0.96% |
Price to Book | 1.68 x | 1.71 x | 1.72 x | 0.78 x | 1.74 x | 1.69 x |
Nbr of stocks (in thousands) | 17,068 | 17,068 | 17,068 | 17,068 | 17,068 | 17,068 |
Reference price 2 | 12.75 | 12.58 | 12.25 | 5.550 | 11.75 | 11.50 |
Announcement Date | 4/30/19 | 4/28/20 | 5/8/21 | 5/1/22 | 4/27/23 | 3/24/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 244.7 | 246.9 | 248 | 259.1 | 263.2 | 258.4 |
EBITDA | - | - | - | - | - | - |
EBIT 1 | 3.835 | 3.192 | 2.9 | -3.123 | -5.774 | 2.268 |
Operating Margin | 1.57% | 1.29% | 1.17% | -1.21% | -2.19% | 0.88% |
Earnings before Tax (EBT) 1 | 5.669 | 3.259 | 2.323 | -1.594 | -4.901 | 3.33 |
Net income 1 | 3.44 | 1.461 | 1.189 | -3.77 | -4.743 | 1.927 |
Net margin | 1.41% | 0.59% | 0.48% | -1.46% | -1.8% | 0.75% |
EPS 2 | 0.2015 | 0.0856 | 0.0697 | -0.2209 | -0.2779 | 0.1129 |
Free Cash Flow 1 | 3.417 | -1.581 | 6.025 | -3.187 | -4.729 | -2.149 |
FCF margin | 1.4% | -0.64% | 2.43% | -1.23% | -1.8% | -0.83% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | 99.33% | - | 506.62% | - | - | - |
Dividend per Share 2 | 0.0300 | 0.0100 | 0.0100 | 0.0200 | - | - |
Announcement Date | 4/30/19 | 4/28/20 | 5/8/21 | 5/1/22 | 4/27/23 | 3/24/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | 5.93 | 9.12 | - | 21.6 | 27.8 |
Net Cash position 1 | 5.37 | - | - | 3.13 | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 3.42 | -1.58 | 6.03 | -3.19 | -4.73 | -2.15 |
ROE (net income / shareholders' equity) | 2.68% | 1.15% | 0.96% | -3.09% | -4% | 1.67% |
ROA (Net income/ Total Assets) | 0.16% | 0.13% | 0.12% | -0.12% | -0.22% | 0.08% |
Assets 1 | 2,138 | 1,118 | 1,026 | 3,095 | 2,156 | 2,273 |
Book Value Per Share 2 | 7.570 | 7.370 | 7.140 | 7.150 | 6.750 | 6.790 |
Cash Flow per Share 2 | 0.9000 | 0.4600 | 0.2700 | 0.6000 | 0.2500 | 0.6900 |
Capex | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - |
Announcement Date | 4/30/19 | 4/28/20 | 5/8/21 | 5/1/22 | 4/27/23 | 3/24/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- PKIN Stock
- Financials Pekin Life Insurance Company